{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:35:45Z","timestamp":1774917345432,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1172978"],"award-info":[{"award-number":["1172978"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006065","name":"Department of Health, Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>While it has been postulated that opioid poisoning during pregnancy may cause adverse maternal and neonatal outcomes, the harm associated with opioid poisoning during pregnancy has not been robustly examined. Pregnant women admitted to hospital or presenting to the emergency department (ED) in Western Australia (WA) with a diagnosis of opioid poisoning were identified by linking state midwifery records with hospital and ED administrative data. Maternal and neonatal outcomes were compared with opioid poisoning that occurred in the 12\u00a0months prior to conception or the 12\u00a0months following birth. Between 2003 and 2018, 57 neonates were born to women who had experienced opioid poisoning during pregnancy (14.1 per 100,000 births) in WA. The incidence of opioid poisoning in the year prior to pregnancy (IRR: 3.04, 95%CI: 2.30, 4.02) and the year following pregnancy (IRR: 1.96, 95%CI: 1.46, 2.64) was significantly higher than during pregnancy. Opioid poisoning during pregnancy was less likely to involve multiple substances and be intentional (rather than accidental). Neonatal conditions associated with in utero hypoxia were significantly less common in neonates born to women who experience opioid poisoning prior to pregnancy compared with during pregnancy (OR: 0.17, 95%CI: 0.04, 0.80). Opioid poisoning in pregnancy was not associated with an increased risk of other serious adverse neonatal outcomes. Opioid poisoning during pregnancy is uncommon and less likely to be intentional and involve multiple substances. Opioid poisoning during pregnancy is likely associated with an increased risk of conditions associated with in utero hypoxia.<\/jats:p>","DOI":"10.1007\/s00737-022-01260-6","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T04:02:32Z","timestamp":1660881752000},"page":"957-963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Opioid poisoning during pregnancy: prevalence, characteristics, and neonatal outcomes"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0841-2216","authenticated-orcid":false,"given":"Erin","family":"Kelty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwyn","family":"Pyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2982-2169","authenticated-orcid":false,"given":"David B.","family":"Preen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"1260_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/bmj.302.6769.137","volume":"302","author":"L Appleby","year":"1991","unstructured":"Appleby L (1991) Suicide during pregnancy and in the first postnatal year. BMJ 302:137\u2013140","journal-title":"BMJ"},{"key":"1260_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/ajo.12761","volume":"58","author":"J Blandthorn","year":"2018","unstructured":"Blandthorn J, Bowman E, Leung L, Bonomo Y, Dietze P (2018) Managing opioid overdose in pregnancy with take-home naloxone. Aust N Z J Obstet Gynaecol 58:460\u2013462","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"1260_CR3","doi-asserted-by":"publisher","first-page":"e0116231","DOI":"10.1371\/journal.pone.0116231","volume":"10","author":"CS Cornford","year":"2015","unstructured":"Cornford CS, Close HJ, Bray R, Beere D, Mason JM (2015) Contraceptive use and pregnancy outcomes among opioid drug-using women: a retrospective cohort study. PLoS One 10:e0116231","journal-title":"PLoS One"},{"key":"1260_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1467-842X.1999.tb01297.x","volume":"23","author":"CDAJ Holman","year":"1999","unstructured":"Holman CDAJ, Bass AJ, Rouse IL, Hobbs MST (1999) Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 23:453\u2013459","journal-title":"Aust N Z J Public Health"},{"key":"1260_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drugpo.2017.05.039","volume":"46","author":"E Kelty","year":"2017","unstructured":"Kelty E, Hulse G (2017a) Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone. Int J Drug Policy 46:54\u201360","journal-title":"Int J Drug Policy"},{"key":"1260_CR6","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s40265-017-0763-8","volume":"77","author":"E Kelty","year":"2017","unstructured":"Kelty E, Hulse G (2017b) A retrospective cohort study of birth outcomes in neonates exposed to naltrexone in utero: a comparison with methadone-, buprenorphine- and non-opioid-exposed neonates. Drugs 77:1211\u20131219","journal-title":"Drugs"},{"key":"1260_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0143-4004(97)90000-X","volume":"18","author":"JCP Kingdom","year":"1997","unstructured":"Kingdom JCP, Kaufmann P (1997) Oxygen and placental villous development: origins of fetal hypoxia. Placenta 18:613\u2013621","journal-title":"Placenta"},{"key":"1260_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","volume":"151","author":"EA Kiyatkin","year":"2019","unstructured":"Kiyatkin EA (2019) Respiratory depression and brain hypoxia induced by opioid drugs: morphine, oxycodone, heroin, and fentanyl. Neuropharmacology 151:219\u2013226","journal-title":"Neuropharmacology"},{"key":"1260_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.drugalcdep.2017.01.003","volume":"174","author":"KB Kozhimannil","year":"2017","unstructured":"Kozhimannil KB, Graves AJ, Jarlenski M, Kennedy-Hendricks A, Gollust S, Barry CL (2017) Non-medical opioid use and sources of opioids among pregnant and non-pregnant reproductive-aged women. Drug Alcohol Depend 174:201\u2013208","journal-title":"Drug Alcohol Depend"},{"key":"1260_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","volume":"121","author":"A Maeda","year":"2014","unstructured":"Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR (2014) Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology 121:1158\u20131165","journal-title":"Anesthesiology"},{"key":"1260_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1176\/ajp.154.12.1720","volume":"154","author":"PM Marzuk","year":"1997","unstructured":"Marzuk PM, Tardiff K, Leon AC, Hirsch CS, Portera L, Hartwell N, Iqbal MI (1997) Lower risk of suicide during pregnancy. Am J Psychiatry 154:122\u2013123","journal-title":"Am J Psychiatry"},{"key":"1260_CR12","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/AOG.0000000000001695","volume":"128","author":"TD Metz","year":"2016","unstructured":"Metz TD, Rovner P, Hoffman MC, Allshouse AA, Beckwith KM, Binswanger IA (2016) Maternal deaths from suicide and overdose in Colorado, 2004\u20132012. Obstet Gynecol 128:1233\u20131240","journal-title":"Obstet Gynecol"},{"key":"1260_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","volume":"132","author":"DM Schiff","year":"2018","unstructured":"Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, Bharel M, Wilens TE, Larochelle M, Walley AY, Land T (2018) Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol 132:466\u2013474","journal-title":"Obstet Gynecol"},{"key":"1260_CR14","unstructured":"The national statement on ethical conduct in human research (2007) National Health and Medical Research Council, Canberra"},{"key":"1260_CR15","doi-asserted-by":"publisher","first-page":"906723","DOI":"10.1155\/2014\/906723","volume":"2014","author":"VE Whiteman","year":"2014","unstructured":"Whiteman VE, Salemi JL, Mogos MF, Cain MA, Aliyu MH, Salihu HM (2014) Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy 2014:906723","journal-title":"J Pregnancy"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-022-01260-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00737-022-01260-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-022-01260-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T12:31:14Z","timestamp":1663763474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00737-022-01260-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1260"],"URL":"https:\/\/doi.org\/10.1007\/s00737-022-01260-6","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"2 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EK and DP have received research funding from MunidPharma for an unrelated project. AP has no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}